Streetbeat News

Stock Prices

HYZN

Trading for a certain asset was halted at 7:50:00 p.m. ET due to pending news. The halt indicates that significant information is expected to be released, which could impact the asset's price.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 11:50 pm

BAC

BRK

FTXO

IYG

KBWB

Bank of America CEO Brian Moynihan praised Warren Buffett as an investor but has not inquired about Buffett's recent reduction in BofA shares. Berkshire Hathaway has sold nearly $7 billion in BofA shares since mid-July. Moynihan discussed manageable capital rule changes and potential impacts on lending. BofA's Q3 investment banking revenue is expected to slightly increase. BofA shares and related ETFs fell on Tuesday.

Portfolio Pulse from Michael Juliano

September 10, 2024 | 10:07 pm

CNI

CN has recovered from labor uncertainties and adjusted its 2024 guidance, now expecting low single-digit EPS growth due to labor issues and wildfires. The long-term outlook for 2024-2026 targets high single-digit EPS growth.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 10:03 pm

CPRT

Copart (NASDAQ:CPRT) has significantly outperformed the market over the past 15 years, with an annualized return of 22.37%. A $1000 investment in Copart 15 years ago would now be worth $21,197.75, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 9:30 pm

BRO

Brown & Brown (NYSE:BRO) has significantly outperformed the market over the past 5 years, with an annualized return of 23.55%. A $1000 investment in BRO 5 years ago would now be worth $2,866.31, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 9:30 pm

BNED

Barnes & Noble Education (NYSE:BNED) reported Q1 sales of $263.4 million, missing estimates and showing a slight decline from last year. The decrease was due to store closures, though BNC First Day programs saw a 32% revenue increase. The company plans $20 million in capital expenditures for FY 2025, focusing on store and tech improvements. Shares fell over 5% after the report.

Portfolio Pulse from Erica Kollmann

September 10, 2024 | 9:23 pm

JNJ

Johnson & Johnson reports that dexamethasone significantly reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung cancer treated with intravenous RYBREVANT. The study showed a three-fold reduction in IRRs compared to standard management.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 9:21 pm

HWM

Howmet Aerospace (NYSE:HWM) has significantly outperformed the market over the past 5 years, with an annualized return of 34.9%. A $1000 investment in HWM 5 years ago would now be worth $4,486.02. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 9:00 pm

APP

Analysts have provided mixed evaluations of AppLovin (NASDAQ:APP) over the past three months, with a range of ratings from bullish to bearish. The average 12-month price target has increased to $94.33. AppLovin has shown strong financial performance with significant revenue growth and high net margins, but it also has a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 9:00 pm

PH

Parker Hannifin (NYSE:PH) has significantly outperformed the market over the past 5 years, with an average annual return of 26.53%. A $100 investment in PH 5 years ago would now be worth $318.88, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 9:00 pm